HALLOWEEN SALE - 25% OFF

NEW Selling losers for tax season? Check the wash-sale window first

Our free Wash Sale Calculator shows the first day you can buy back — and flags buys that would cancel your tax loss.

Check a trade »

Amgen Inc. AMGN | NASDAQ

$460.42 -$18.06 | -3.77%

TREND SIGNAL: Signal available — unlock to view

Signal available — unlock to view

|2026-09-30

Add to favoritesFavorite

Company Overview:

Market Cap: $249.01B

Trailing PE: 26.7x

FWD PE *: 19x

Payout Ratio (TTM): 42.6%

52-Week Range: $302.13 - $483.99

* Forward PE is based on street estimates.

10 Year AMGN Performance Metrics:

Total Return (with DRIP): 338.5% (15.93% CAGR)

Total Return (no DRIP): 279.3% (14.26% CAGR)

Share Price: 240.0% (13.02% CAGR)

Yield on Cost (with DRIP): 9.60%

Total Invested: $10,000

Total Value (with DRIP): $43,846

Total Return $ (with DRIP): $33,846

Dividend Increase: 119.1% (8.36% CAGR)

Dividend Yield (FWD): 2.19% ($10.08)

AMGN 10-yr Total Return ($10K invested)

1M 3M 6M YTD 1Y 3Y 5Y 10Y

AMGN Share Price

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

AMGN Price CAGR:1Y: 43.94%2Y: 20.08%5Y: 16.58%10Y: 13.02%

AMGN Dividend Charts

AMGN - Dividends

AMGN Dividend CAGR:1Y: 5.88%2Y: 5.83%5Y: 7.44%10Y: 9.68%

AMGN - Dividend Payout Ratio

AMGN Dividend Payout Ratio CAGR:1Y: -11.51%2Y: -9.17%5Y: -7.83%10Y: -0.49%

AMGN - Dividend to Free Cash Flow Ratio

AMGN Dividend to FCF Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Build Custom Charts

AMGN - Chart 1

AMGN - Chart 2

AMGN - Chart 3

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $128.25/yr ($10.69/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Trend Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 44% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $216/yr ($18/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 44% Lifetime Discount

ULTRA

$576 ($48/mo) $432/yr ($36/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 44% Lifetime Discount

AMGN Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

AMGN - Revenue

AMGN Revenue CAGR:1Y: 8.45%2Y: 10.41%5Y: 9.10%10Y: 5.96%

AMGN - Earnings Per Share (EPS)

AMGN EPS CAGR:1Y: 19.39%2Y: 16.46%5Y: 16.42%10Y: 10.20%

AMGN - Net Income

🔓 See the full chart25% off right now · 7-day free trial

AMGN Net Income CAGR:1Y: 20.15%2Y: 16.85%5Y: 15.45%10Y: 6.72%

AMGN - EBITDA

🔓 See the full chart25% off right now · 7-day free trial

AMGN EBITDA CAGR:1Y: 9.27%2Y: 10.69%5Y: 21.39%10Y: 8.95%

AMGN - Free Cash Flow

🔓 See the full chart25% off right now · 7-day free trial

AMGN Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMGN - Free Cash Flow / Share

🔓 See the full chart25% off right now · 7-day free trial

AMGN Free Cash Flow / Share CAGR:1Y: -14.46%2Y: 4.62%5Y: 11.97%10Y: 6.88%

AMGN - Operating Income

🔓 See the full chart25% off right now · 7-day free trial

AMGN Operating Income CAGR:1Y: 46.87%2Y: 34.63%5Y: 9.30%10Y: 3.91%

AMGN - Gross Profit

🔓 See the full chart25% off right now · 7-day free trial

AMGN Gross Profit CAGR:1Y: 17.02%2Y: 20.79%5Y: 8.25%10Y: 4.71%

AMGN - Shares Outstanding

🔓 See the full chart25% off right now · 7-day free trial

AMGN Shares Outstanding CAGR:1Y: 0.74%2Y: 0.37%5Y: -0.86%10Y: -3.16%

AMGN - Share Buybacks

🔓 See the full chart25% off right now · 7-day free trial

AMGN Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMGN - Stock-Based Comp

🔓 See the full chart25% off right now · 7-day free trial

AMGN Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMGN - Expenses

🔓 See the full chart25% off right now · 7-day free trial

AMGN Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMGN - Revenue vs Net Income

🔓 See the full chart25% off right now · 7-day free trial

AMGN - EPS vs FCF / Share

🔓 See the full chart25% off right now · 7-day free trial

AMGN - EPS vs PE Ratio

🔓 See the full chart25% off right now · 7-day free trial

AMGN - FCF vs FCF / Share

🔓 See the full chart25% off right now · 7-day free trial

AMGN - FCF vs Stock Based Comp

🔓 See the full chart25% off right now · 7-day free trial

AMGN - Cash & Debt

🔓 See the full chart25% off right now · 7-day free trial

AMGN - Revenue by Segment

🔓 See the full chart25% off right now · 7-day free trial

AMGN Revenue CAGR:1Y: 8.45%2Y: 10.41%5Y: 9.10%10Y: 5.96%

AMGN - Revenue by Region

🔓 See the full chart25% off right now · 7-day free trial

AMGN Revenue CAGR:1Y: 8.45%2Y: 10.41%5Y: 9.10%10Y: 5.96%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

AMGN - REVENUE: Actual + Estimates

🔓 See the full chart25% off right now · 7-day free trial

AMGN Actual Revenue CAGR:1Y: 8.45%2Y: 10.41%5Y: 9.10%10Y: 5.96%

AMGN - EPS: Actual + Estimates

🔓 See the full chart25% off right now · 7-day free trial

AMGN Actual EPS CAGR:1Y: 19.39%2Y: 16.46%5Y: 16.42%10Y: 10.20%

AMGN - NET INCOME: Actual + Estimates

🔓 See the full chart25% off right now · 7-day free trial

AMGN Actual Net Income CAGR:1Y: 20.15%2Y: 16.85%5Y: 15.45%10Y: 6.72%

AMGN - EBITDA: Actual + Estimates

🔓 See the full chart25% off right now · 7-day free trial

AMGN Actual EBITDA CAGR:1Y: 9.27%2Y: 10.69%5Y: 21.39%10Y: 8.95%

Ratios, Profit Margins & Return on Capital:

AMGN - Net Profit Margin

🔓 See the full chart25% off right now · 7-day free trial

AMGN Net Profit Margin CAGR:1Y: 10.79%2Y: 5.84%5Y: 5.82%10Y: 0.72%

AMGN - Gross Profit Margin

🔓 See the full chart25% off right now · 7-day free trial

AMGN Gross Profit Margin CAGR:1Y: 7.90%2Y: 9.41%5Y: -0.78%10Y: -1.18%

AMGN - Price to Earnings

🔓 See the full chart25% off right now · 7-day free trial

AMGN Price to Earnings CAGR:1Y: 25.10%2Y: -1.74%5Y: -1.60%10Y: -0.45%

AMGN - Price To Sales Ratio

🔓 See the full chart25% off right now · 7-day free trial

AMGN Price To Sales Ratio CAGR:1Y: 38.49%2Y: 3.98%5Y: 4.12%10Y: 0.26%

AMGN - Return on Capital Employed

🔓 See the full chart25% off right now · 7-day free trial

AMGN Return on Capital Employed CAGR:1Y: 37.86%2Y: 32.53%5Y: 1.45%10Y: 3.15%

AMGN - Return on Invested Capital

🔓 See the full chart25% off right now · 7-day free trial

AMGN Return on Invested Capital CAGR:1Y: 38.41%2Y: 27.03%5Y: -2.17%10Y: 2.46%

AMGN Dividends Info:

Annual Dividend: $10.08

Forward Yield: 2.19%

Ex-Dividend Date: 2026-08-21

Lifetime Dividends / Share: $87.21

AMGN Dividend History: Dates, Payments & Yield list

Below is a schedule of all AMGN dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date	Payment Date	Amount	Yield	Forward Yield	Price on Ex-Date
08/21/2026	08/24/2026	$2.520	2.29%	2.27%	$443.84
05/15/2026	05/18/2026	$2.520	3.09%	3.11%	$324.39
02/13/2026	02/16/2026	$2.520	2.73%	2.73%	$369.53
11/21/2025	11/24/2025	$2.380	2.82%	2.85%	$334.30
08/22/2025	08/25/2025	$2.380	3.24%	3.3%	$288.47
05/16/2025	05/19/2025	$2.380	3.49%	3.45%	$275.85
02/14/2025	02/17/2025	$2.380	3.27%	2.93%	$324.86
11/18/2024	11/20/2024	$2.250	3.23%	3.13%	$287.87
08/16/2024	08/19/2024	$2.250	2.8%	2.74%	$327.97
05/17/2024	06/07/2024	$2.250	2.88%	2.95%	$305.02
05/16/2024	05/20/2024	$2.250	2.86%	2.86%	$314.54
02/15/2024	02/19/2024	$2.250	3.11%	3.3%	$272.86
11/16/2023	11/20/2023	$2.130	3.17%	3.21%	$265.35
08/17/2023	08/21/2023	$2.130	3.23%	3.27%	$260.70
05/17/2023	05/19/2023	$2.130	3.79%	3.81%	$223.42
02/14/2023	02/16/2023	$2.130	3.53%	3.64%	$234.22
11/16/2022	12/08/2022	$1.940	2.73%	2.72%	$285.57
08/17/2022	09/08/2022	$1.940	3.1%	3.16%	$245.45
05/16/2022	06/08/2022	$1.940	3.18%	3.16%	$245.48
02/14/2022	03/08/2022	$1.940	3.46%	3.36%	$231.10
11/15/2021	12/08/2021	$1.760	3.39%	3.3%	$213.53
08/16/2021	09/08/2021	$1.760	3.05%	3.19%	$220.87
05/14/2021	06/08/2021	$1.760	2.8%	2.97%	$236.82
02/11/2021	03/08/2021	$1.760	3%	3.09%	$227.81
11/13/2020	12/08/2020	$1.600	2.7%	2.8%	$228.94
08/14/2020	09/08/2020	$1.600	2.67%	2.65%	$241.18
05/15/2020	06/08/2020	$1.600	2.66%	2.83%	$225.75
02/13/2020	03/06/2020	$1.600	2.87%	3.04%	$210.65
11/14/2019	12/06/2019	$1.450	2.65%	2.48%	$233.77
08/14/2019	09/06/2019	$1.450	2.92%	2.79%	$207.73
05/16/2019	06/07/2019	$1.450	3.41%	3.3%	$175.51
02/14/2019	03/08/2019	$1.450	3.11%	3.21%	$180.87
11/15/2018	12/07/2018	$1.320	2.74%	2.76%	$191.44
08/16/2018	09/07/2018	$1.320	2.69%	2.69%	$196.30
05/16/2018	06/08/2018	$1.320	3.04%	2.86%	$184.30
02/14/2018	03/08/2018	$1.320	2.94%	2.82%	$187.16
11/16/2017	12/08/2017	$1.150	2.69%	2.62%	$175.41
08/15/2017	09/08/2017	$1.150	2.71%	2.55%	$180.64
05/15/2017	06/08/2017	$1.150	2.88%	2.83%	$162.65
02/13/2017	03/08/2017	$1.150	2.74%	2.59%	$177.78
11/14/2016	12/08/2016	$1.000	2.73%	2.85%	$140.59
08/15/2016	09/08/2016	$1.000	2.29%	2.34%	$170.97
05/13/2016	06/08/2016	$1.000	2.63%	2.53%	$158.00
02/11/2016	03/08/2016	$1.000	2.83%	2.77%	$144.63
11/12/2015	12/07/2015	$0.790	2.09%	2%	$158.30
08/13/2015	09/08/2015	$0.790	1.87%	2.04%	$154.56
05/12/2015	06/05/2015	$0.790	2%	2.01%	$157.25
02/10/2015	03/06/2015	$0.790	2.07%	2.04%	$154.88
11/10/2014	12/05/2014	$0.610	1.5%	1.44%	$169.24
08/12/2014	09/05/2014	$0.610	1.93%	1.77%	$137.88
05/13/2014	06/06/2014	$0.610	2.2%	2.07%	$117.82
02/11/2014	03/07/2014	$0.610	2.01%	2%	$122.26
11/12/2013	12/06/2013	$0.470	1.67%	1.65%	$114.12
08/14/2013	09/06/2013	$0.470	1.76%	1.69%	$111.01
05/14/2013	06/07/2013	$0.470	1.74%	1.9%	$98.81
02/11/2013	03/07/2013	$0.470	2.21%	2.02%	$92.95
11/13/2012	12/07/2012	$0.360	1.68%	1.63%	$88.32
08/14/2012	09/07/2012	$0.360	1.72%	1.72%	$83.96
05/14/2012	06/07/2012	$0.360	2.05%	2.08%	$69.10
02/13/2012	03/07/2012	$0.360	2.11%	2.15%	$66.95
11/15/2011	12/08/2011	$0.280	1.98%	1.92%	$58.40
08/16/2011	09/08/2011	$0.280	2.18%	2.02%	$55.31

Projected Future Returns & Dividends for AMGN

Based on past 10-year performance, here are AMGN growth metrics:

Share price CAGR of +13.02%
Dividend CAGR of +9.73%

Using AMGN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	AMGN (DRIP)	AMGN - No DRIP
Current Price	$460.42	$460.42
Start Shares	21.72	21.72
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	26.31	21.72
Dividends Payment	$6.38	$6.38
Annual Dividends	$671	$554
Yield on cost	6.71%	5.54%
Share Price	$1,565.63	$1,565.63
Total Dividends	$3,860	$3,444
Final Value	$41,197	$37,448

Estimated Future Value + Dividends - AMGN

NOTE: Above numbers are our estimate based on AMGN's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $128.25/yr ($10.69/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Trend Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 44% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $216/yr ($18/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 44% Lifetime Discount

ULTRA

$576 ($48/mo) $432/yr ($36/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 44% Lifetime Discount

Company Info

Amgen Inc. (AMGN) had its IPO on 1983-06-17, and is traded on NASDAQ stock exchange.

Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products. Notable examples include Enbrel, prescribed for conditions like plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, which helps cancer patients by reducing the risk of infection linked to a low white blood cell count; Prolia, utilized in postmenopausal women to combat osteoporosis; and Xgeva, designed to prevent skeletal-related complications. Otezla offers relief for adult patients suffering from plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease. Aranesp addresses anemia and low red blood cell counts, while KYPROLIS is employed to treat patients with relapsed or refractory multiple myeloma. Furthermore, Repatha plays a vital role in lowering the incidence of major cardiovascular events such as myocardial infarction, stroke, and coronary revascularization. Amgen's comprehensive product lineup also encompasses Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. The company distributes its therapies worldwide, primarily serving healthcare providers, including physicians and their clinics, dialysis centers, hospitals, and pharmacies. Distribution is facilitated through pharmaceutical wholesale distributors, complemented by direct-to-consumer channels. Amgen actively engages in strategic collaborations. It has partnered with entities such as Novartis Pharma AG, UCB, Bayer HealthCare LLC, BeiGene, Ltd., Eli Lilly and Company, Datos Health, and Verastem, Inc., to jointly assess VS-6766 when combined with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. Another key alliance involves Kyowa Kirin Co., Ltd., for the co-development and commercialization of KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody targeting atopic dermatitis and other autoimmune conditions. Additionally, Amgen maintains research and development partnerships with Neumora Therapeutics, Inc. and Plexium, Inc.

AMGN website: https://www.amgen.com

Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $128.25/yr ($10.69/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Trend Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 44% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $216/yr ($18/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 44% Lifetime Discount

ULTRA

$576 ($48/mo) $432/yr ($36/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 44% Lifetime Discount

Loading signals…

DCF Model — AMGN

Value from:

EPS (TTM)icompany profit per share over the last 12 months

EPS Growth %ihow fast profit per share grows each of the next 5 years — prefilled with what analysts expect

EPS growth after year 5 (forever)ithe slower pace once the fast 5 years are over — only drives years 6-10 of the price path below

Exit multiple (PE in 5 yrs)iwhat buyers pay per $1 of profit in 2031 — prefilled with today’s forward PE

Desired return %/yrithe yearly return you want from buying today — the S&P has done ~14%/yr, ask for more from a single stock

FCF growth %/yr (next 5 yrs)ihow fast free cash flow grows while the company is still expanding fast

Years of fast FCF growthihow many years the fast growth lasts before the business settles down

FCF growth after year 5 (forever)ithe slow, steady pace once the company is mature — usually 2-3%, near inflation. Must stay below your target return

Risk-free rate %iwhat a 10-yr US treasury pays with zero risk — the floor any risky stock must beat

Your target return %/yrithe yearly return you want for taking this risk — rule of thumb: risk-free rate + extra for risk

FCF base ($M, TTM)ilast 12 months of free cash flow, added up from reported quarters

Include dividends in returnidividends hand you part of the return in cash, so the share price needs to climb less

Pay up to today

—

vs current price $460.42

—

Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today

—

grows for the next years

Then mature

—

every future dollar counted back to today

Pile of today-dollars

—

÷ shares

Implied price path

Year	FCF	Implied price

Sensitivity — fair value: growth ↓ × target return →

× Free Portfolio Tracker

Own AMGN? See every dividend it's paid you

Add your AMGN shares to a free account and every payment you've received is listed — dated, in dollars — with reinvested shares counted and monthly totals. Room for 4 more stocks.

✓Every AMGN dividend you've received, dated, with the amount
✓Reinvested (DRIP) shares counted for you
✓Monthly totals across up to 5 stocks

Add AMGN free →

Free plan · up to 5 holdings